IL18 and neoplasm: This functional duality underscores IL-18’s capacity to either promote tumour eradication through immune effector cell activation or paradoxically facilitate tumour progression via microenvironmental reprogramming, necessitating precision-based evaluation of its therapeutic modulation20.